Home
News
Create
Screeners
Insights
Trimurthi
57.
16
+2.72
(+5.00%)
Market Cap
₹63.21 Cr
PE Ratio
-
Industry
Retail
Buy
Sell
Company Performance:
1D
+5.00%
1M
+14.76%
6M
+104.58%
1Y
+114.81%
5Y
+114.81%
View Company Insights
Latest news about Trimurthi
Trimurthi Reports Robust Q2 FY2026 Results with Net Profit of Rs 52.47 Crore
Nov 14, 2025
Trimurthi, an active pharmaceutical ingredients manufacturer and trader, announced unaudited financial results for Q2 FY2026. The company's total income rose to Rs 3,639.14 crore from Rs 387.37 crore in Q2 FY2025. Net profit increased to Rs 52.47 crore from Rs 12.95 crore. Half-year total income stood at Rs 5,874.26 crore with a net profit of Rs 64.03 crore. The company's balance sheet showed total assets of Rs 7,180.33 crore and total equity of Rs 2,560.96 crore. Ms. Monam Kapoor resigned as Independent Non-Executive Director.
Trimurthi Appoints New Director and Allots 16.61 Lakh Equity Shares
Oct 23, 2025
Novelix Pharmaceuticals Partners with German Research Institute for Astaxanthin Production
Oct 16, 2025
Novelix Pharmaceuticals Appoints New Directors and Secretarial Auditor
Sep 21, 2025
Novelis Reports 36% Drop in Q1 Net Income Despite 13% Sales Growth
Aug 11, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation